APOE and Alzheimer disease: In reevaluating the hypothesis of APOE ε4 being an anatomically selective risk factor that increases vulnerability to AD pathology in medial temporal regions alone [10], the current results noting higher odds of visuospatial initial symptoms among LRP APOE ε4 carriers points to parietotemporal regions also as potential brain regions of vulnerability to APOE ε4’s effect.